ATTACH.MPID_Dated_16_March_2017.pdf

REF NO. OF DOC BEING CONT’D PAGE OF PAGES

NAME OF OFFEROR OR CONTRACTOR

CONTINUATION SHEET

DATE: March 16, 2017

SPECIFICATION SHEET FOR ROUTINE PROCUREMENT

NSN: 6850-01-618-1533

ITEM IDENTIFICATION: WATER PURIFICATION TABLETS, 50s

SALIENT CHARACTERISTICS.

Shall be Water Purification Tablets, intended for emergency disinfection of drinking water.

Each tablet shall contain 8 mg of Iodine. Each treatment shall consist of 2 tablets.

Each bottle shall contain sufficient tablets for 25 treatments.

Shall be supplied in a suitable square or round light-resistant, amber-colored, wide-mouth glass bottle. The void in the bottle shall be filled by a pledget of suitable poly material suitable to protect and preserve the tablets from damage.

The bottle shall be supplied with a primary closure and a secondary moisture vapor-resistant closure, such as a suitable wax cap seal, which shall preserve the tablets from damages to the fullest extent possible. Wax cap seal shall be thinner and shall utilize an adhesive.

Contents of unopened bottles should remain effective up to 48 months, provided they are maintained under controlled temperatures between 60 - 86°F (15 - 30°C). Protect the tablets from exposure to heat, humidity, moisture and air, to avoid reduction of effectiveness.

NSN: 6850-01-618-1533

Once a bottle is opened, keep the cap tightly sealed. Contents of opened bottles should remain effective up to 12 months. After 12 months dispose of any remaining contents of the opened bottle.

Contractor Certification: the contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producer’s own drawings, specifications, standards and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.

REGULATORY REQUIREMENTS.

ENVIRONMENTAL PROTECTION AGENCY (EPA). Shall be in accordance with the Federal Insecticide, Fungicide and Rodenticide Acts Amended and Regulations Promulgated Thereunder (40 CFR Part 162).

U. S. FOOD AND DRUG ADMINISTRATION. If the product covered by this document has been determined by the U.S. Food and Drug Administration to be under its jurisdiction, the offeror/contractor shall comply, and be responsible for compliance by its subcontractor’s/suppliers, with the requirements of the Federal Food, Drug and Cosmetic Act, as amended, and regulations promulgated thereunder. In addition, the offeror/contractor shall comply, and be responsible for compliance by its subcontractors/suppliers, with the requirements of all other applicable Federal, State, and local statutes, ordinances, and regulations.

Workmanship. Tablets shall be free from defects which detract from their appearance or impair their serviceability.

Recovered Materials. The offeror/contractor is encouraged to use recovered materials in accordance with the Federal Acquisition Regulation (FAR) Subpart 23.4 to the maximum extent practical.

QUALITY ASSURANCE PROVISIONS

Responsibility for inspection. Unless otherwise specified in the contract, the contractor is responsible for the performance of all inspection requirements, as specified herein. Except as otherwise specified in the contract, the contractor may use his own or any other facilities suitable for the performance of the inspection requirements specified herein, unless disapproved by the Government. The Government reserves the right to perform any of the inspections set forth in the specifications, where such inspections are deemed necessary to assure supplies and services conform to prescribed requirements.

Records. Records of examinations and tests performed by or for the contractor shall be maintained by the contractor and made available to the Government, upon the Government’s request, at any time, or from time to time, during the performance of the contract and for a period of three years after delivery of the supplies to which such records relate.

No company supplying any raw materials to the contractor will be considered an acceptable facility for the performance of any inspection requirements specified herein.

PREPARATION FOR DELIVERY

Packaging and packing.

Commercial.

The subject commodity shall be packaged and packed to meet the standard practice for commercial packaging. Exterior (shipping) containers shall be substantial commercial containers (export when necessary) of the type, size and kind commonly used for the purpose, so constructed as to insure acceptance and safe delivery by common or other carriers, at the lowest rate, to point of delivery called for in the contract or order.

Unitized loads shall be used whenever total quantity for shipment to one destination exceeds 250 lbs (excluding the pallet) or 20 cubic feet. Unitized loads may be commercial type 4-way entry pallets. Pallet shall have a length of 40 inches and a width of 48 inches.

Pallet loads, including the pallet, shall not exceed 54 inches in height, 43 inches in length and 52 inches in width.

REF NO. OF DOC BEING CONT’D

Packaging and packing quantities.

Unit. Bottle (BT). Each bottle shall contain 50 tablets.

Labeling and marking.

Each bottle shall be marked as specified in Medical Marking Standard No. 1A. Markings shall include the manufacture, part number, complete item description, EPA Reg #, NSN, quantity, unit of issue, manufacture lot number, date of manufacture and expiration date.

Each bottle shall be marked in accordance with Federal and State regulatory requirements.

REF NO. OF DOC BEING CONT’D _

Each intermediate package (if supplied), exterior (shipping) container and palletized unit load shall be marked as specified in Medical Marking Standard No. 1A. Marking shall include the NSN, cage code, the lot (control) number and date of manufacture prefixed by "MFD”, manufacturer’s product/part number item identification, quantity, unit of issue, delivery order number (e.g. SPM2DP-12-D-0001-XXXX).